???????????????????? ??????????????????????????????????????????????????????????Negotiations above the 2022 reauthorization advise that market priorities consist of greater application of true-environment evidence, regulatory certainty, and greater interaction between FDA and sector during the drug software process.PDUFA was originally meant to be a… Read More